BOSTON, Nov. 1, 2016 /PRNewswire/ -- BTL Aesthetics today announced the release of a peer review study, published in the Journal of Drugs in Dermatology (JDD), addressing effectiveness and patient satisfaction of three "hands-free" noninvasive body contouring devices: cryolipolysis, 1060nm diode laser, and BTL Vanquish ME. The study, written by Drs. Suneel Chilukuri and Gregory Meuller, analyzed peer reviewed studies on the three devices and their mechanism of action, as well as on their evidence of safety and efficacy.
Based on the facts presented, BTL Vanquish ME was proven to be more cost effective and to remove fat faster—three to five times more speed coverage, per treatment regimen—over a higher coverage area. "We are excited to see this review published, as it shows that BTL Vanquish ME satisfies body sculpting patients' needs: Efficacy and speed in fat removal, but also cost efficiencies," said Tomas Boleslavsky, Director of Clinical at BTL Aesthetics. "This data, coupled with other research, actually allowed us to calculate the cost of fat removal per ounce—which, for BTL Vanquish ME, is $78/ounce compared to nearly $1K for our competitors." BTL Vanquish ME is a physician-favored treatment that is FDA-cleared for the circumferential reduction of the abdomen and thighs. The clearance was secured following several rounds of clinical testing to provide ample evidence of its efficacy and safety—which has also been previously documented thanks to articles published in peer-reviewed journals. BTL Vanquish ME is unique in the market, as it was also awarded a patent in September for the method in which the device uses feedback power control for non-invasive treatment of skin and human tissue. This patented method allows BTL Vanquish ME to deliver the optimum amount of entry to the patient, while reducing the thermal load of the patient and device.